Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Controlled Trial to Investigate the Effect of an Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

NCT05603104 is registered in ClinicalTrials.gov with Dr. Inge Winter as lead sponsor.

NCT NCT05603104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05603104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Controlled Trial to Investigate the Effect of an Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Lead sponsor
Dr. Inge Winter
Phase
Phase 3
Overall status
Recruiting
Start date
April 27, 2025
Completion date
June 30, 2028
Enrollment
1,254 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, major depressive disorder, schizophrenia and related disorders